Clinical Trials Browser

Phase 1 × etaracizumab × Tumor-Agnostic × Clear all

NCT00263783 2009-01-29

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

Phase 1 Completed

Neoplasms